Late stent thrombosis after drug-eluting stent: Seeing is understanding

Circulation

Volumn 120, Issue 5, 2009, Pages 364-365

  Wijns, William ^a  

^a CARDIOVASCULAR CENTER   (Belgium)

Author keywords

Editorials; Remodeling; Stents; Thrombosis

Indexed keywords

BIOMATERIAL; C REACTIVE PROTEIN; GALLIUM; ISOBUTYLENE; METHACRYLIC ACID DERIVATIVE; PACLITAXEL; RAPAMYCIN; STYRENE DERIVATIVE;

BIOCOMPATIBILITY; CORONARY STENT; DRUG ELUTING STENT; EDITORIAL; EOSINOPHIL; HEART INFARCTION; HEART SCINTISCANNING; HISTOPATHOLOGY; HUMAN; HYPEREOSINOPHILIA; HYPERSENSITIVITY REACTION; INTRAVASCULAR ULTRASOUND; PATHOGENESIS; PRIORITY JOURNAL; SAFETY; STENT THROMBOSIS;

CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; HUMANS; VASCULITIS;

EID: 68249113188     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.882001     Document Type: Editorial

References (7)

1. Cook S, Ladich E, Nakazawa G, Eshtehard P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, Gay S, Meier B, Pichler WJ, Jüni P, Virmani R, Windecker S. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation. 2009;120:391-399.
2. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Jüni P, Vaina S, Hellige G, Tsuchida K, Morger C, Boersma E, Kukreja N, Meier B, Serruys PW, Windecker S. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52:1134-1140.
3. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115:2426-2434.
4. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370:937-948.
5. Kritharides L, Yiannikas J, Brieger D, Allman K. Coronary uptake of gallium-67 citrate after implantation of sirolimus-eluting stent. Circulation. 2004;109:2156.
6. Hoffmann R, Morice MC, Moses JW, Fitzgerald PJ, Mauri L, Breithardt G, Schofer J, Serruys PW, Stoll HP, Leon MB. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart. 2008;94:322-328.
7. Niccoli G, Schiavino D, Belloni F, Ferrante G, La Torre G, Conte M, Cosentino N, Montone RA, Sabato V, Burzotta F, Trani C, Leone AM, Porto I, Pieroni M, Patriarca G, Crea F. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents. Eur Heart J. 2009;30:1340-1347.